| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/31/1995 | US5385898 Hypertensive agents; cardiovascular disorders; renin inhibitors; glaucoma |
| 01/31/1995 | CA1334200C Leukotriene antagonists |
| 01/31/1995 | CA1334197C Hetera-aliphatic carboxamides |
| 01/27/1995 | CA2127384A1 Substituted azepino ¬2,1-a| isoquinoline compounds |
| 01/26/1995 | WO1995002686A1 Redirection of cellular immunity by receptor chimeras |
| 01/26/1995 | WO1995002598A1 Fused cycloalkylimidazopyridines |
| 01/26/1995 | WO1995002597A1 IMIDAZO[4,5-c]PYRIDIN-4-AMINES |
| 01/26/1995 | WO1995002592A1 N-(piperidinyl-1-alkyl)-substituted cyclohexane carboxylic acid amides as 5-ht1a receptor antagonists |
| 01/26/1995 | WO1995002591A1 Tri-substituted imidazoles having multiple therapeutic properties |
| 01/26/1995 | WO1995002587A1 Substituted piperazinylcamphor derivatives as oxytocin antagonists |
| 01/26/1995 | WO1995002583A1 Process for making hiv protease inhibitors |
| 01/26/1995 | WO1995002577A1 Novel vitamin d analogues |
| 01/26/1995 | WO1995002420A2 Prodrugs of protein tyrosine kinase inhibitors |
| 01/26/1995 | WO1995002409A2 Use of vitamin d and derivatives thereof for the manufacture of a medicament for protection against neuron loss |
| 01/26/1995 | WO1995002405A1 Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists |
| 01/26/1995 | CA2167313A1 N-(piperidinyl-1-alkyl)-substituted cyclohexane carboxylic acid amides as 5-ht1a receptor antagonists |
| 01/26/1995 | CA2167311A1 Tri-substituted imidazoles having multiple therapeutic properties |
| 01/26/1995 | CA2167153A1 Prodrugs of protein tyrosine kinase inhibitors |
| 01/26/1995 | CA2167042A1 Imidazo[4,5-c]pyridin-4-amines |
| 01/26/1995 | CA2166974A1 Substituted amide derivatives of piperizinylcamphor sulfonyl and carbonyl oxytocin antagonists |
| 01/26/1995 | CA2162040A1 Novel vitamin d analogues |
| 01/25/1995 | EP0635507A1 Tricyclic derivatives and their use as anti-cancer agents |
| 01/25/1995 | EP0635501A1 Tris carbamic acid esters: inhibitors of cholesterol absorption; inhibitors of ACAT and CEH |
| 01/25/1995 | EP0635497A2 Benzospiroalkene derivatives, process for their preparation and pharmaceutical compostions containing them |
| 01/25/1995 | EP0635496A2 Benzospiroalkene derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/25/1995 | EP0635495A2 Benzospiroalkene derivates, process for their preparation and pharmaceutical compositions containing them |
| 01/25/1995 | EP0635491A1 (Thia) cycloalkyl(b)indoles, process of their preparation and compositions containing it |
| 01/25/1995 | EP0635479A1 Perylene quinones (UCN-1028 D) derivatives |
| 01/25/1995 | EP0635270A1 Parathyroid hormone and raloxifene for increasing bone mass |
| 01/25/1995 | EP0635268A1 Inhibition of phosphatidylinositol 3-kinase with wortmannin and analogs thereof |
| 01/25/1995 | EP0635060A1 Myogenic vector systems |
| 01/25/1995 | EP0635029A1 Cartilage matrix protein and methods for use |
| 01/25/1995 | EP0635018A1 4-(1H-2-METHYLIMIDAZO 4,5-c]PYRIDINYLMETHYL)PHENYLSULPHONAMIDE DERIVATIVES AS ANTAGONISTS OF PAF |
| 01/25/1995 | EP0635017A1 Indole derivatives as 5-ht1 agonists |
| 01/25/1995 | EP0635003A1 Perhydroisoindole derivatives as p substance antagonists |
| 01/25/1995 | EP0634896A1 Evaluation and treatment of patients with progressive immunosuppression |
| 01/25/1995 | CN1097761A Polycyclic compounds and processes for the preparation thereof |
| 01/25/1995 | CN1097756A Heterotricyclically substituted phenyl-cyclohexane-carboxylic acid derivatives |
| 01/25/1995 | CN1097749A Benzofuranyl- and -thiopheny-alkanecarboxyclic acid derivatives |
| 01/25/1995 | CN1097744A Urea derivative containing heterocyclic ring |
| 01/25/1995 | CN1097743A 9H-imidazo|1,2-a¨benzimidazole-3-acetamide derivative and preparation and pharmaceuctical application of same |
| 01/25/1995 | CN1097740A Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides |
| 01/25/1995 | CN1097737A Substituted benzoylguanide preparation and pharmaceutical application of same |
| 01/25/1995 | CN1097735A Derivative of fatty acid and pharmaceutical composition containg same |
| 01/25/1995 | CN1027504C Imidazolyl-alkenoic acids |
| 01/25/1995 | CN1027503C Crystalline salt of 4-(di-n-propyl) amino-6-aminocarbonyl-1,3,4,5-tetrahydrohbonz|cd¨indole |
| 01/24/1995 | US5384332 Methods for inhibiting aortal smooth muscle cell proliferation and restenosis with 1,1,2-triphenylbut-1-ene derivatives |
| 01/24/1995 | US5384322 Nitrogen-containing bicyclic compounds and pharmaceutical compositions thereof |
| 01/24/1995 | US5384320 N-hydroxyurea derivatives which inhibit lipoxygenase |
| 01/24/1995 | US5384319 Aminoalkylphenyl compounds |
| 01/24/1995 | US5384310 2'-fluoro-2-haloarabinoadinosines and their pharmaceutical compositions |
| 01/24/1995 | US5384119 Respiratory system disorders, antiarthritic agents |
| 01/24/1995 | CA2038409C Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase |
| 01/24/1995 | CA1334095C Aroyl urea and carbamic acid derivatives |
| 01/23/1995 | CA2128464A1 Bicyclic heterocyclic compounds, pharmaceutical preparations containing these compounds and processes for their preparation |
| 01/23/1995 | CA2128376A1 Parathyroid hormone and raloxifene for increasing bone mass |
| 01/22/1995 | CA2128116A1 Tris carbamic acid esters: inhibitors of cholesterol absorption |
| 01/21/1995 | CA2128283A1 (thia)cycloalkyl¬b|indoles, their preparation process and pharmaceutical compositions containing them |
| 01/20/1995 | CA2128046A1 Inhibition of phosphatidylinositol 3-kinase with wortmannin and analogs thereof |
| 01/19/1995 | WO1995002069A1 Oligonucleotide modulation of protein kinase c |
| 01/19/1995 | WO1995001995A1 Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices |
| 01/19/1995 | WO1995001990A1 Hemoregulatory penta- or hexapeptides |
| 01/19/1995 | WO1995001980A1 Bicyclic tetrahydro pyrazolopyridines |
| 01/19/1995 | WO1995001976A1 Indoline derivatives as 5ht2c antagonists |
| 01/19/1995 | WO1995001974A1 Piperidinyl substituted methanoanthracenes as d1/d2-antagonists and 5ht2-serotanin-antagonists |
| 01/19/1995 | WO1995001972A1 Heme binding compounds and use thereof |
| 01/19/1995 | WO1995001960A1 Novel structural analogues of vitamin d |
| 01/19/1995 | WO1995001956A1 Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants |
| 01/19/1995 | CA2166624A1 Indoline derivatives as 5ht2c antagonists |
| 01/19/1995 | CA2166222A1 Heme binding compounds and use thereof |
| 01/19/1995 | CA2166058A1 Oligonucleotide modulation of protein kinase c |
| 01/19/1995 | CA2163994A1 Piperidinyl substituted methanoanthracenes as d1/d2-antagonists and 5ht2-serotanin-antagonists |
| 01/18/1995 | EP0634401A1 MDR reversal agents |
| 01/18/1995 | EP0634396A1 Amino acid derivatives and their use as inhibitors of encephalinase |
| 01/18/1995 | EP0634173A1 24-epi-1-alpha-hydroxyvitamin D2 for treating osteoporosis |
| 01/18/1995 | EP0633883A1 Process for the preparation of 4-pyridyl- and 4-piperidinylimidazoles useful as intermediates for the synthesis of histamine receptor antagonists |
| 01/18/1995 | EP0633779A1 USE OF $g(b)-CARBOLINES |
| 01/18/1995 | EP0633778A1 Medicament for the treatment of airways inflammation and airways hyperresponsiveness |
| 01/18/1995 | EP0633776A1 Compounds useful for treating allergic and inflammatory diseases |
| 01/18/1995 | EP0549686A4 Modified internucleoside linkages |
| 01/18/1995 | CN1097421A Adhesion receptor antagonists |
| 01/18/1995 | CN1097420A Sulfonate and carbamate derivatives of 3-aroylbenzo|B¨thiophenes |
| 01/18/1995 | CN1097419A New preparation process for sulphurated derivatives of imidazole and the new intermediates obtained |
| 01/18/1995 | CN1097417A 新的杂环化合物 New heterocyclic compounds |
| 01/17/1995 | US5382675 Polycyclic compounds and processes for the preparation thereof |
| 01/17/1995 | US5382657 Peg-interferon conjugates |
| 01/17/1995 | US5382431 Administering a heat stable peptone digest complexed with an ionic transition metal to accelerate healing of topical wounds in mammals |
| 01/17/1995 | CA2128139A1 Mdr reversal agents |
| 01/14/1995 | CA2127735A1 Pyrimidones and imidazolinones for treatment of shock |
| 01/12/1995 | WO1995001434A1 A truncated keratinocyte growth factor (kgf) having increased biological activity |
| 01/12/1995 | WO1995001431A1 Peptide family, designated as xenonins |
| 01/12/1995 | WO1995001372A1 Peptidase resistant thrombin receptor peptide ligand |
| 01/12/1995 | WO1995001370A1 Higher order structure and binding of peptide nucleic acids |
| 01/12/1995 | WO1995001369A1 Double-stranded peptide nucleic acids |
| 01/12/1995 | WO1995001350A1 Tetrazole derivatives having antihistaminic and antiallergic activity |
| 01/12/1995 | WO1995001349A1 Arylidene and heteroarylidene oxindole derivatives as tyrosine kinase inhibitors |
| 01/12/1995 | WO1995001348A2 Imides as inhibitors of tnp alpha |
| 01/12/1995 | WO1995001338A1 Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors |
| 01/12/1995 | WO1995001326A1 Anti-atherosclerotic diaryl compounds |
| 01/12/1995 | CA2626178A1 Process for the preparation of thalidomide |